In the BioHarmony Drug Report Database

"Preview" Icon

Dronedarone

Multaq (dronedarone) is a small molecule pharmaceutical. Dronedarone was first approved as Multaq on 2009-07-01. It is used to treat atrial fibrillation and cardiac arrhythmias in the USA. It has been approved in Europe to treat atrial fibrillation. It is known to target potassium voltage-gated channel subfamily A member 5. Multaq’s patents are valid until 2031-06-30 (FDA).

 

Trade Name

 

Multaq
 

Common Name

 

dronedarone
 

ChEMBL ID

 

CHEMBL184412
 

Indication

 

atrial fibrillation, cardiac arrhythmias
 

Drug Class

 

Antirrhythmics

Image (chem structure or protein)

Dronedarone structure rendering